{{Rsnum
|rsid=2059693
|Gene=INHA
|Chromosome=2
|position=219577768
|Orientation=plus
|GMAF=0.309
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 53.6 | 39.3 | 7.1
| HCB | 51.8 | 40.9 | 7.3
| JPT | 51.3 | 40.7 | 8.0
| YRI | 35.4 | 47.9 | 16.7
| ASW | 33.3 | 52.6 | 14.0
| CHB | 51.8 | 40.9 | 7.3
| CHD | 58.7 | 36.7 | 4.6
| GIH | 19.8 | 62.4 | 17.8
| LWK | 39.1 | 53.6 | 7.3
| MEX | 41.4 | 48.3 | 10.3
| MKK | 57.1 | 34.0 | 9.0
| TSI | 43.1 | 46.1 | 10.8
| HapMapRevision=28
}}A study of 577 cases of testicular germ cell tumors, the most common [[testicular cancer]] in young men, concluded that the [[rs2059693]](T) allele increased risk. Among Caucasians, the odds ratio for the [[rs2059693]](C;T) genotype was 1.33 (CI: 1.04-1.71), and for the (T;T) genotype, 1.60 (CI: 1.01-2.52, p(trend) = 0.008). The association with [[rs2059693]] was even stronger for nonseminomas, and for teratomas and teratocarcinomas in particular (N = 58; (C;T) odds ratio 1.63, CI: 0.89-2.99; (T;T) odds ratio 4.54, CI: 2.00-10.3, p(trend) = 0.0008).{{PMID|18413775|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}